Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
CD4CAR for Acute Myeloid Leukemia
Recruiting1 awardPhase 1
Indianapolis, Indiana
This trial is testing a new treatment for patients with relapsed or refractory AML (a type of leukemia). The goal is to see if the treatment is safe and if it can help eliminate the
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.